Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy
Clinical trial NCT02402231 · UNKNOWN
Trial details
- NCT number
- NCT02402231
- Sponsor
- Caroline Nilsson
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2020-10-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.